Genetic recombination that occurs with high frequency during poliovirus genome replication is a process whose molecular mechanism is poorly understood. Studies of genetic recombination in a cell-free system in vitro and in infected tissue culture cells in vivo have led to the unexpected observation that temperature strongly influences the loci at which cross-over between the two recombining RNA strands occurs. Specifically, cross-over between two genetically marked RNA strands in vitro and in vivo at 34°C occurred over a wide range of the genome. In contrast, recombination in vivo at 37 and 40°C yielded cross-over patterns that had shifted dramatically to a region encoding nonstructural proteins. Preferential selection of recombinants at 37 and 40°C was ruled out by analyses of the growth kinetics of the recombinants. During the studies of recombination in the cell-free system we found that there is a direct correlation between the ability of a poliovirus RNA molecule to replicate in the cell-free system and its capacity to complement de novo virus synthesis programmed by another viral RNA.
INTRODUCTION
The high error rate in genome replication and the phenomenon of recombination lead to genetic variation of RNA viruses that accounts for the astounding diversity among RNA virus families (Holland et al., 1990) . Interestingly, genetic recombination has been observed only with plus-strand RNA viruses that, in turn, can use this mechanism to remove debilitating or even lethal mutations from a replicating genome (King, 1988a; Lai, 1992; Jarvis and Kirkegaard, 1992; Wimmer et al., 1993; Cao and Wimmer, 1996) . Although studied with species of many different plus-strand RNA families Lai et al., 1985; Bujarski and Kaesberg, 1986; Kirkegaard and Baltimore, 1986; Palasingam and Shaklee, 1992; Cascone et al., 1993 , and references therein), the mechanism(s) by which genetic information is exchanged between two genomes can be different and this depends on a given virus family (Lai, 1992) . In no case have all details of the molecular events of genetic recombination been elucidated.
Genetic recombination of RNA viruses was first described for poliovirus by Hirst (1962) . Although received with skepticism, an abundance of data has led to the conclusion that poliovirus recombination is homologous and that it results from minus-strand switching during genome replication (reviewed in Jarvis and Kirkegaard, 1991; Wimmer et al., 1993) . Indeed, genetic recombination occurs with high frequency between sibling strands in infections with a single genotype (Cao and Wimmer, 1996) . Moreover, recombinants between the three serotypes of the Sabin poliovirus vaccine strains can be readily detected in specimens of vaccine recipients (Kew and Nottay, 1984) . One of the many questions yet to be answered is: what factors influence the RNA polymerase 3D pol to pause so that the nascent minus strand can search for, and attach to, another plus-strand template? In other words, what determines the cross-over points ?
We (Duggal et al., 1997) and others (Tang et al., 1997) have recently succeeded in achieving genetic recombination of poliovirus in vitro, that is, in cell-free extracts capable of supporting de novo poliovirus proliferation. This cell-free system consists of cytoplasmic extracts of uninfected HeLa cells devoid of nuclei, mitochondria, and cellular mRNAs that, when seeded with infectious poliovirus mRNA, leads to translation and replication of the input RNA followed by encapsidation of newly synthesized genomes (Molla et al., 1991) . In our experiments, we made use of selectable markers separated by several thousand nucleotides, and we scored for recombinants by growing newly synthesized virus under restrictive conditions. Specifically, we crossed wild-type poliovirus [PV1(M)g s ] whose replication is naturally sensitive to the presence of 2 mM guanidine hydrochloride (Gua-HCl; Pincus and Wimmer, 1986 ) with a chimeric virus, PV1(RIPO)g r , a poliovirus whose internal ribosomal entry site (IRES) (Jang et al., 1988 (Jang et al., , 1989 Pelletier and Sonenberg, 1988) was exchanged with the IRES element of human rhinovirus type 2 (HRV2; Gromeier et al., 1996) . This chimera replicates very well in HeLa cells but it is highly restricted in human neuroblastoma cells (Gromeier et al., 1996) . In addition, PV1(RIPO)g r carried a mutation in the coding region of the virus-encoded 2C
ATPase that conferred resistance to 2 mM Gua-HCl (Duggal et al., 1997; Pfister and Wimmer, 1998) . Using these parents we have now analyzed in more detail the cross-over points between the two genotypes, and we have compared the in vitro recombination results with those obtained in vivo (in infected HeLa cells). Specifically, we were interested in the effect of temperature on recombination. We report that temperature (34°C vs 37 or 40°C) greatly influences the region of the genome where cross-over occurs. Although the reason for this phenomenon is currently unknown, we speculate that higher order RNA structures may play a role in template switching.
In the course of our studies of recombination in the cell-free system we also observed that active replication of polioviral RNA is required for complementation of another replication-impaired poliovirus RNA in the in vitro system.
RESULTS
Complementation in the cell-free system is dependent on RNA replication
In our previous experiments (Duggal et al., 1997) , recombinants between two polioviral strains were isolated using two selectable markers: sensitivity to 2 mM GuaHCl, a phenotype mapping to the viral 2C ATPase in the PV1(M)g s parent (Pincus and Wimmer, 1986; Pfister and Wimmer, 1998) , and inability to proliferate in human neuroblastoma cells (SK-N-MC) due to the replacement of the cognate IRES with that of HRV2 [PV1(RIPO), Gromeier et al., 1996] . PV1(RIPO) also had a mutation that conferred resistance to 2 mM Gua-HCl and was thus called the PV1(RIPO)g r parent. During these cell-free recombination studies we found that the replication of PV1(RIPO)g r RNA could be complemented by PV1(M)g s RNA to yield infectious virus five orders of magnitude higher than when no PV1(M)g s RNA was present in the reaction mixture (Duggal et al., 1997) . The PV1(M)g s RNA and PV1(RIPO)g r RNA used for these recombination studies were isolated from cesium chloride-purified poliovirions. To analyze the complementation phenomenon further we employed two different RNA transcripts generated by in vitro transcription with T7 transcriptase from the same poliovirus cDNA [encoding PV1(M)g s ]. The first transcript was obtained after the plasmid was linearized at the EcoRI (RI) restriction site, the second after it was linearized at the PvuI restriction site, two loci downstream of the genome-encoded poly(A) tail (Fig. 1) . Whereas the RI-linearized transcript carries three extra nonviral bases 3Ј to the poly(A) tail, the PvuI transcript has 626 nonviral nucleotides downstream of the poly(A) tail. It is important to note that both transcripts are equally efficient as mRNA in the HeLa cell-free system (data not shown). However, these two types of polioviral transcripts were found to express large differences in their ability to replicate in the cell-free system. When analyzed under identical conditions, the reactions programmed with the PvuI transcripts (PVM txpt. PvuI) produced very little, if any, virus [Ͻ10 plaque-forming units (PFU)/ml], whereas the RI transcript (PVM txpt. RI) produced virus titers two orders of magnitude lower than RNA from cesium chloride-purified poliovirions (PVM vRNA; Fig. 1 ). The latter, of course, has an authentic 3Ј-terminal poly(A) (Yogo and Wimmer, 1972) .
To determine the effects of the two types of RNA transcripts on the complementation of replication of PV1(RIPO)g r RNA, we coincubated the virion-purified PV1(RIPO)g r RNA with either of the two types of RNA transcripts in the cell-free system. The yield of PV1(RIPO)g r was then assayed on HeLa cells in the presence of Gua-HCl. The yield of recombinants was assayed on SK-N-MC cells in the presence of Gua-HCl and subtracted from the PV1(RIPO)g r virus yield. The PvuI transcript complemented PV1(RIPO)g r replication very poorly, whereas the RI transcript provided excellent support for PV1(RIPO)g r replication, with 1000 ng of this transcript complementing PV1(RIPO)g r replication to levels very similar to 600 ng of PVM vRNA (Fig. 2) . We interpret these data to mean that replication of PV1(RIPO)g r in the cell-free system can be complemented in trans, but that this is dependent on the replication ability of the complementing RNA molecule (see Discussion).
Generation of additional markers to further map cross-over sites
In our previous study on cell-free recombination, by using silent genetic markers (restriction sites) all the recombinants between the two polioviral strains were found to have arisen by cross-over between the parental strains that had occurred between the SacI and the StuI restriction sites in PV1(RIPO)g r ( Fig. 3 ; Duggal et al., 1997) .
To further define the region of recombination, we have now introduced four additional restriction sites in the coding region for the P1 structural protein of PV1(M)g s . The sites in the 5Ј to 3Ј direction are SalI (position nt 1098), SacI (position nt 1902), BglII (position nt 2686), and SalI (position nt 3332) (Fig. 3) . The mutagenesis to create the restriction sites was carried out to alter the codons but to retain the amino acid sequence of the proteins.
FIG. 2. The ability of a polioviral RNA to complement the replication of PV1(RIPO)g
r RNA replication depends on its capacity to replicate in the cell-free system. The polioviral cDNA is depicted above the bar chart. The polioviral ORF is shown as an open box and the lines on either side represent the 5Ј and 3Ј untranslated regions. The two restriction sites used for linearizing the cDNA for carrying out run-off transcription, the EcoRI site (adds 3 extra nonviral bases) and the PvuI site (adds 626 nonviral bases), are shown. In the bar graph the columns represent the various amounts of polioviral transcript RNAs and viral RNA (along the X axis) that complement the replication of PV1(RIPO)g r shown in terms of virus titer in log 10 PFU/ml along the Y axis. The yield of PV1(RIPO)g r in the absence of coreplicating wt polioviral RNA is 10 2 PFU/ml (Duggal et al., 1997) .
FIG. 3.
Mapping of cross-over sites for five recombinants that were generated in the poliovirus cell-free system from one representative experiment. The genome representation for wild-type PV, PV1(M)g s with the four new silent restriction sites and that of PV1(RIPO)g r with previous restrictions sites and the marker for Gua-HCl resistance (g r ) are shown. Below the genome representation are agarose gels showing RT-PCR products of the PV1(M)g s , PV1(RIPO)g r , and five recombinants after being digested with restriction enzymes SalI and BglII (A&B), with restriction enzyme SacI (C), and with restriction enzyme StuI (D). All the gels shown are 0.8% agarose gels. Lanes 5 in A&B, C, and D contain a DNA molecular weight marker. Sizes of the bands are indicated to the left.
Transcript RNA of the variant cDNA, carrying the additional four silent restriction sites, was used to transfect HeLa cells. The resulting virus had a burst and plaque size identical to that of wild-type virus (data not shown).
Cell-free recombination using the new PV1(M)g s variant Recombination reactions were carried out in the cellfree system at 34°C (Molla et al., 1993) using viral RNAs of the PV1(M)g s variant carrying the four additional markers in the structural protein region as well as viral RNA of PV1(RIPO)g r (Duggal et al., 1997) . Recombinants were selected on the neuroblastoma cell line SK-N-MC (Gromeier et al., 1996) in the presence of 1 mM Gua-HCl. In variation with our previous study, we have reduced the Gua-HCl concentration from 2 to 1 mM as this aided growth of the SK-N-MC cells while at the same time it still inhibited the growth of the PV1(M)g s parent (data not shown).
Plaques of 17 recombinants from 10 separate reactions were picked from SK-N-MC cells (Duggal et al., 1997) . Viruses from different plaques were used to infect SK-N-MC cells in the presence of 1 mM Gua-HCl and viral RNA was extracted from the infected cells and subjected to RT-PCR analyses. To examine cross-over sites using the newly generated restriction sites, a 2802-bp PCR product covering most of the structural protein region and part of protein 2A was digested with the enzymes restricting at the respective new sites (Figs. 3A, 3B, and 3C). As expected, the PCR product for the parent PV1(RIPO)g r was not digested by either of the restriction enzymes (Fig. 3A, 3B , and 3C, lanes 2), whereas the PCR product for the variant PV1(M)g s parent was digested with all four restriction enzymes specific for the new sites (Figs. 3A, 3B, and 3C, lanes 1). Using the new sites and a previously created StuI site unique for the PV1(RIPO)g r genome (Duggal et al., 1997) , mapping of the cross-over sites of five recombinants generated in the cell-free system from a representative experiment is shown in Fig. 3 (lanes 3, 4, 6 , 7, and 8). In Fig. 4A , a bar graph is used to show the fraction of the recombinants (percentage of the total of 17 recombinants) under their respective regions of cross-over between the genomes of PV1(M)g s and PV1(RIPO)g r . This graph does not show any apparent preference for a specific site in the genomic RNAs for cross-over to occur.
Comparison of cross-over patterns in the HeLa cell-free system to cross-over patterns in infected HeLa cells at 37°C
We were interested to compare the results of in vitro recombination (at 34°C) with those of recombination in infected HeLa cells at the physiological temperature of 37°C. Particular emphasis was given to compare the cross-over pattern in vitro to that in vivo.
HeLa cells were coinfected at equal multiplicities of infection (MOIs) with PV1(M)g s and PV1(RIPO)g r parent viruses at 37°C (see Materials and Methods). Recombinants were selected by plating the cytoplasmic extracts on monolayers of SK-N-MC in the presence of 1 mM Gua-HCl. Plaques of recombinants were picked, the viruses were propagated, and the genotypes were determined as described for the in vitro recombinants. The pattern of cross-over for 20 recombinants from 10 coinfections, as determined by RT-PCR analyses and restriction digestions, are shown in Fig. 4B . It should be noted that an additional previously created restriction site (XhoI), unique for the PV1(RIPO)g r genome, was employed (Duggal et al., 1997) . Unexpectedly, the pattern of cross-over sites that emerged at 37°C in vivo differed significantly from that obtained for recombinants in the cell-free system at 34°C (compare Fig. 4A with 4B ). Only 10% of the recombinants at 37°C in vivo crossed over in the sequences specifying the capsid coding proteins, a region where 70.5% of the recombinants mapped in the cell-free system.
Altering the in vivo temperature changes the cross-over pattern
Poliovirus cell-free synthesis occurs maximally at 34°C, whereas at higher temperatures (Ն36°C), the yield of virus is extremely low, if detectable at all (Molla et al., 1993) . Thus, it was impossible to repeat the in vitro experiments at 37°C and compare the results with the in vivo results described here. Therefore, we carried out the in vivo experiments at 34°C to determine whether the in vitro cross-over pattern was peculiar to the cell-free system or related to the temperature at which genome replication occurs.
HeLa cells were coinfected with PV1(M)g s and PV1(RIPO)g r parent viruses as described above but incubation of the infected cells was carried out at 34°C. From 8 coinfections, 12 recombinants were recovered and subjected to RT-PCR followed by restriction digestion analyses. Remarkably, the cross-over pattern of the recombinants obtained in vivo at 34°C had significantly changed. It did not show a preference for a specific region of the poliovirus genome. Rather, it was quite similar to that obtained for the recombinants recovered in the cell-free system (compare Fig. 5A with 5B).
Coinfections of HeLa cells with the same parent viruses were also carried out at 40°C. Twenty-five recombinant plaques were examined from 11 coinfections. The cross-over pattern of the recombinants obtained at this temperature was similar to that obtained at 37°C, but it was different from that observed in vivo at 34°C and from that of the cell-free system (Fig. 6) . Especially pronounced was the fraction of recombinants in the region of cross-over between the StuI and the XhoI sites. At 34°C about 25% of in vivo recombinants crossed over in this region, at 37°C the percentage of total in vivo recombinants went up to 40%, and at 40°C, about 50% of the total recombinants crossed over in this region.
Growth kinetics of recombinants at different cross-over regions
It could be argued that the different patterns of crossover resulted from selection of the recombinants based on superior growth at the higher or lower temperatures. We tested this possibility by comparing the growth kinetics of several recombinants at 40°C. Specifically, we used two recombinants that had arisen from frequent cross-over between the StuI and XhoI sites (Stu-Xho), one recombinant that had crossed over between the 5Ј SalI site and the SacI site (Sal-Sac), and one recombinant that had the cross-over junction between the SacI and the BglII sites (Sac-Bgl). The latter two recombinants fall into the group of infrequent cross-overs.
One-step growth experiments with these recombinants at 40°C revealed very similar growth kinetics (Fig.   FIG. 4 . Pattern of cross-over of the recombinants obtained in the cell-free system at 34°C and after recombination in vivo at 37°C. The six different regions of cross-over as defined by the new restriction sites on PV1(M)g s and the previously existing restriction sites on PV1(RIPO)g r are shown by six differently shaded columns between the two genomes. The bar graphs below the genomes represent the percentage of the total recombinants generated in the cell-free system at 34°C (A) and in vivo at 37°C (B) that had crossed over in each of the six defined regions of cross-over. 7), an observation suggesting that crossing over between the StuI and the XhoI sites at 40°C did not give an undue replication advantage to the progeny recombinants at this temperature. A slight difference in the growth curves is an apparently earlier uncoating event for one of the StuI-XhoI recombinants (Fig. 7, solid cir- cles). We believe that this is due to experimental variation.
We conclude that the distinct cross-over patterns observed at a given temperature in vivo did not result from selection of recombinants that were especially fit to replicate at this temperature.
FIG. 5.
Pattern of cross-over of the recombinants obtained in the cell-free system at 34°C and after recombination in vivo at 34°C. The six different regions of cross-over as defined by the new restriction sites on PV1(M)g s and the previously existing restriction sites on PV1(RIPO)g r are shown by six differently shaded columns between the two genomes. The bar graphs below the genomes represent the percentage of the total recombinants generated in the cell-free system at 34°C (A) and in vivo at 34°C (B) that had crossed over in each of the six defined regions of cross-over.
DISCUSSION
A major unsolved question in genetic recombination of poliovirus is the signal at which the nascent minusstrand decides to leave its cognate template and switch to another template. Clearly, the viral RNA polymerase 3D pol must pause during minus-strand synthesis (Kirkegaard and Baltimore, 1986) to give the replication complex a chance to adopt the new template. Are pausing and cross-over a random phenomenon followed by selection of genotypes during subsequent replication [a mechanism favored by Kirkegaard (1991, 1992) ]? Or are pausing and cross-over favored in regions of distinct secondary structure of the parental template [a mechanism favored by Agol and his colleagues (Romanova et al., 1986; Tolskaya et al., 1987) ]? Are there additional cis-acting sequence signals that favor crossover (King, 1988b) ?
Our data are not adequate to make a decision be- tween these possible mechanisms. However, the pronounced change in cross-over patterns as the result of temperature can be explained if RNA structures promote the site of 3D pol pausing and recombination. The formation of specific structures (combined with protein interactions?) could depend on a given temperature, a phe-FIG. 7. One-step growth kinetics of four recombinant isolates at 40°C in HeLa cells in the presence of 2 mM Gua-HCl. Black circles and gray squares indicate two independent recombinants that had crossed over within the dominant region between the StuI and the XhoI sites. Open triangles and open circles represent the recombinants that had crossed over at the less frequent regions between the 5Ј SalI-SacI sites and the SacI-BglII sites, respectively. The X axis represents hours postinfection (hpi) and the Y axis shows log 10 PFU/ml. nomenon that may influence the progression of the replication complex.
A correlation between secondary structures and recombination has also been reported for foot-and-mouth disease virus, in which the cross-over sites were found to be located in regions of RNA that had a tendency to have strong secondary structure (Wilson et al., 1988) . Particularly striking is the structure-specific determination of cross-over sites that has been identified in subviral RNAs of the plant virus, turnip crinkle virus (Cascone et al., 1993) . The mechanism as to how RNA secondary structure could favor recombination is still a matter of speculation. In a model proposed by Romanova et al. (1986) , the formation of intermolecular duplexes between regions of pronounced secondary structure was speculated to induce pausing and strand switching (reviewed in Wimmer et al., 1993) .
Preferred recombination 3Ј of the StuI site in vivo, as we have described here, was also observed by Tolskaya et al. (1987) , who studied intertypic poliovirus recombination at 37°C. In contrast, Kirkegaard and Baltimore (1986) did not find sequence-related determination of cross-over sites for intertypic poliovirus recombinants. Kirkegaard and Baltimore (1986) , however, studied recombination in vivo at 32°C. Our data serve to explain this discrepancy in cross-over sites by the two groups.
The accumulation of region-specific cross-over at a given temperature is not the result of selection of recombinants that are favored to replicate at temperatures of 34, 37, or 40°C. We have come to this conclusion from similar replication kinetics of recombinant isolates arising by crossing over at three different regions. Hence, the apparent preference for crossing over between the StuI and the XhoI sites is not due to the accumulation of genotypes conferring pronounced fitness to the offspring viruses. Furthermore, the effect of temperature on crossing over, observed in this study, does not appear to be due to significant differences in frequencies of recombination at different temperatures. The frequency of recombination calculated by us for cell-free recombination at 34°C (10 Ϫ4 ; Duggal et al., 1997) is similar to the frequency of recombination observed in vivo at 37°C for the same markers and parents used in the cell-free system (data not shown).
It is tempting to speculate that poliovirus type 1 has evolved such that, at the physiological temperature (37°C), it favors cross-over in the central region of the genome. Whether this may be the case for the other two serotypes of poliovirus will have to be determined. The nucleotide sequences of type 2 and type 3 polioviruses are 71% homologous to the sequence of serotype 1 (Toyoda et al., 1984) . We speculate that genetic exchanges in the coding region of the capsid region would be tolerable only in recombination of sibling strands of a given genotype since the sequences of their capsid region would be nearly identical. Interserotypic recombination of two different serotypes in the capsid region, on the other hand, is likely to be a rare event and could, in addition, lead to replication-deficient, if not lethal, phenotypes. This follows from the fact that the capsid sequences are the most diverse between types 1, 2, and 3 (in disfavor of homologous recombination), and proteolytic processing and folding of the capsid polypeptides are extremely sensitive to changes in the amino acid sequence of the capsid precursor (see, for example, Murray et al., 1988) . Thus, the three serotypes of polioviruses, in order to readily exchange their genetic information by recombination at the physiological temperature, may favor cross-over in the genome region encoding the nonstructural proteins that carries the highest degree of homology.
While studying poliovirus recombination in the cellfree system, we observed that the replication of one of the parents [PV1(RIPO)g r ] could be complemented by the other parent, PV1(M)g s (Duggal et al., 1997) . In the present study we have investigated this phenomenon further and found that two polioviral transcripts with different lengths of nonviral bases downstream of the poly(A) tail express very different abilities to replicate in the cell-free system. This observation reflects, in some respect, a report by Sarnow (1989) , who studied the role of 3Ј-terminal sequences of in vitro synthesized poliovirus transcripts during in vivo poliovirus replication in mammalian cells. Interestingly, in the current study, the ability of a transcript to replicate and yield infectious virus paralleled the ability of the transcript to complement replication of PV1(RIPO)g r . This phenomenon is not the result of different efficiencies by which these transcripts can direct protein synthesis in the cell-free system. We have previously observed that poorly replicating derivatives of the poliovirus genome, regardless of whether assayed in the presence or in the absence of 2 mM Gua-HCl, produced equal amounts of protein in the cell-free system when compared to wild-type poliovirus RNA (Molla et al., 1991; Duggal et al., 1997; Cuconati and Wimmer, unpublished results) . Thus, the inability of the PVM txpt PvuI transcripts to complement PV1(RIPO)g r RNA cannot be due to a decreased supply of viral protein(s) in trans (for example, the Gua-HCl-resistant 2C ATPase ; Pfister and Wimmer, 1998) . Rather, it is likely that the complementing genome may supply a specific complex of proteins that is formed only during replication.
MATERIALS AND METHODS

Plasmid constructions, in vitro transcription, and HeLa cell transfection
Four additional silent restriction sites, two SalI sites, one SacI site, and one BglII site, were generated at positions 1098, 3332, 1902, and 2686 bp, respectively, from the 5Ј end by using the Quickchange mutagenesis kit (Stratagene). The template for the mutagenesis reaction was the cloned polioviral cDNA, pT7PN6 (Trono et al., 1988) . pT7PN6 is the wild-type polioviral cDNA cloned downstream of the T7 promoter but lacks the restriction sites present on the cloned cDNA of PV1(RIPO)g r [pT7PV1(RIPO)g r ] that are also used as markers for determining cross-over sites. pT7PN6 with four new restriction sites was linearized at the PvuI site in the vector and pT7PV1(RIPO)g r was linearized at the FspI site in the vector. Two micrograms of the linearized DNA was used for in vitro transcription reactions using T7 RNA polymerase (van der Werf et al., 1986) . Transcripts were incubated on ice for 30 min with 300 l of 0.5 mg/ml of DEAE dextran (Sigma) in 1ϫ HeBSS buffer (5 g/L of HEPES, 8 g/L of NaCl, 0.36 g/L of KCl, 0.125 g/L of Na 2 HPO 4 ⅐ 2H 2 O, 10 g/L of dextrose). The transcript-DEAE dextran mixture was then spread over HeLa cells (R19) in 35-mm plates. The cells were then rocked on a shaker with the transcript-DEAE dextran mixture for 30 min at room temperature. The mixture was then aspirated off, and the cells were washed once with 1ϫ DMEM (Gibco BRL) and then incubated at 37°C in 1ϫ DMEM containing fetal bovine serum (FBS).
Cells and viruses
HeLa cells (R19) and SK-N-MC cells (a neuroblastoma cell line) were grown in Dulbecco's modified Eagle's medium (DMEM, Gibco BRL) with 5 and 10% FBS, respectively, and 100 /ml of penicillin and 100 mg/ml of streptomycin sulfate (Gibco BRL). Stocks of PV1(M)g s and PV1(RIPO)g r viruses were grown on HeLa cells in 15-cm dishes by propagating supernatants of HeLa cells transfected with the transcripts from the two cDNAs. Plaque assays were carried out as described previously (Duggal et al., 1997) , except that for SK-N-MC cells, (i) 10% fetal bovine serum was used and (ii) when recombinants were being selected 1 mM instead of 2 mM Gua-HCl was used in the noble agar overlay, since the lower concentration of Gua-HCl helps the cells grow better and is adequate for selection. For coinfection experiments PV1(M)g s and PV1(RIPO)g r viruses were used for infecting HeLa cells at an equal MOI of 10.
RNA preparation, cell-free recombination, and RT-PCR analyses
Individual recombinant plaques were picked from SK-N-MC cells grown in the presence of 1 mM Gua-HCl and amplified once in SK-N-MC cells in the presence of 2 mM Gua-HCl for 24 h. Total nucleic acid was extracted as described in Duggal et al. (1997) . RNA from cesium chloride purified virus was extracted as described previously (Duggal et al., 1997) . Cell-free replication and recombination reactions using RNA from cesium chloride-purified virions (viral RNAs) or transcript RNAs were carried out as described previously (Duggal et al., 1997) .
Briefly, for recombination experiments, the 50-l reactions contained 600 ng each of PV1(RIPO)g r and PV1(M)g s viral RNAs. Each 50-l reaction was composed of 35.2 l of a master mix (see below), 8.8 l of virion RNA (1.2 g), and 6 l of micrococcal nuclease-treated rabbit reticulocyte lysate (Promega). The 35.2 l of master mix contained 19.2 l of a S3 HeLa S-10 extract prepared as described by Molla et al. (1991) , 6.56 l of translation mixture (8 mM ATP, 480 M GTP, 80 mM creatine phosphate, 200 g/ml creatine phosphokinase, 150 mM K-HEPES, pH 7.4, 200 g/ml calf liver tRNA, 100 M amino acid mixture without methionine, 2 mM spermidine in 10 mM K-HEPES), 545 M magnesium acetate, 1.3 mM magnesium chloride, 160 mM potassium acetate, 10 M each amino acid (minus leucine or cysteine; Promega), 0.43 unit/l RNasin (Promega), 284 l each of CTP and UTP, and 204 M GTP. The reaction was carried out at 34°C for 12-15 h. For complementation experiments shown in Fig. 2 , 600 ng of PV1(RIPO)g r viral RNA was incubated with various amounts of polioviral transcript RNAs and viral RNA, as shown in the figure. RT-PCR analyses were carried out as described by Duggal et al. (1997) .
